These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 31736563)

  • 41. Impact of Cognitive Profile on Impulse Control Disorders Presence and Severity in Parkinson's Disease.
    Martini A; Weis L; Fiorenzato E; Schifano R; Cianci V; Antonini A; Biundo R
    Front Neurol; 2019; 10():266. PubMed ID: 30967834
    [No Abstract]   [Full Text] [Related]  

  • 42. A survey of impulse control disorders in Parkinson's disease patients in Shanghai area and literature review.
    Wang XP; Wei M; Xiao Q
    Transl Neurodegener; 2016; 5():4. PubMed ID: 26893825
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Trait Impulsivity and Anhedonia: Two Gateways for the Development of Impulse Control Disorders in Parkinson's Disease?
    Houeto JL; Magnard R; Dalley JW; Belin D; Carnicella S
    Front Psychiatry; 2016; 7():91. PubMed ID: 27303314
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A 7-year observation of the effect of subthalamic deep brain stimulation on impulse control disorder in patients with Parkinson's disease.
    Kim A; Kim YE; Kim HJ; Yun JY; Yang HJ; Lee WW; Shin CW; Park H; Jung YJ; Kim A; Ehm G; Kim Y; Jang M; Jeon B
    Parkinsonism Relat Disord; 2018 Nov; 56():3-8. PubMed ID: 30054182
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Long term follow-up of Parkinson's disease patients with impulse control disorders.
    Sohtaoğlu M; Demiray DY; Kenangil G; Ozekmekçi S; Erginöz E
    Parkinsonism Relat Disord; 2010 Jun; 16(5):334-7. PubMed ID: 20223696
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Impulse control and related behaviors in Parkinson's disease with dementia.
    Martinez-Martin P; Wan YM; Ray Chaudhuri K; Schrag AE; Weintraub D
    Eur J Neurol; 2020 Jun; 27(6):944-950. PubMed ID: 32048392
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Behavioral addictions in early-onset Parkinson disease are associated with DRD3 variants.
    Castro-Martínez XH; García-Ruiz PJ; Martínez-García C; Martínez-Castrillo JC; Vela L; Mata M; Martínez-Torres I; Feliz-Feliz C; Palau F; Hoenicka J
    Parkinsonism Relat Disord; 2018 Apr; 49():100-103. PubMed ID: 29361389
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cortical thickness in de novo patients with Parkinson disease and mild cognitive impairment with consideration of clinical phenotype and motor laterality.
    Danti S; Toschi N; Diciotti S; Tessa C; Poletti M; Del Dotto P; Lucetti C
    Eur J Neurol; 2015 Dec; 22(12):1564-72. PubMed ID: 26212370
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Dopaminergic and Opioid Pathways Associated with Impulse Control Disorders in Parkinson's Disease.
    Erga AH; Dalen I; Ushakova A; Chung J; Tzoulis C; Tysnes OB; Alves G; Pedersen KF; Maple-Grødem J
    Front Neurol; 2018; 9():109. PubMed ID: 29541058
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Brain MRI morphometric analysis in Parkinson's disease patients with sleep disturbances.
    Radziunas A; Deltuva VP; Tamasauskas A; Gleizniene R; Pranckeviciene A; Petrikonis K; Bunevicius A
    BMC Neurol; 2018 Jun; 18(1):88. PubMed ID: 29925331
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Impulse control disorders in Parkinson disease: A cross-sectional study in Morocco.
    El Otmani H; Mouni FZ; Abdulhakeem Z; Attar Z; Rashad L; Saali I; El Moutawakil B; Rafai MA; Slassi I; Nadifi S
    Rev Neurol (Paris); 2019 Apr; 175(4):233-237. PubMed ID: 30935674
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Impulse control disorders in Parkinson's disease patients with RLS: a cross sectional-study.
    Marques A; Figorilli M; Pereira B; Derost P; Debilly B; Beudin P; Vidal T; Durif F; Fantini ML
    Sleep Med; 2018 Aug; 48():148-154. PubMed ID: 29913341
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Limbic hypoconnectivity in idiopathic REM sleep behaviour disorder with impulse control disorders.
    Marques A; Roquet D; Matar E; Taylor NL; Pereira B; O'Callaghan C; Lewis SJG
    J Neurol; 2021 Sep; 268(9):3371-3380. PubMed ID: 33709218
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Integrating genetic and clinical data to predict impulse control disorders in Parkinson's disease.
    Jesús S; Periñán MT; Cortés C; Buiza-Rueda D; Macías-García D; Adarmes A; Muñoz-Delgado L; Labrador-Espinosa MÁ; Tejera-Parrado C; Gómez-Garre MP; Mir P
    Eur J Neurol; 2021 Feb; 28(2):459-468. PubMed ID: 33051953
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Linking brain activity during sequential gambling to impulse control in Parkinson's disease.
    Haagensen BN; Herz DM; Meder D; Madsen KH; Løkkegaard A; Siebner HR
    Neuroimage Clin; 2020; 27():102330. PubMed ID: 32688307
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Impulse control disorder in patients with Parkinson's disease under dopamine agonist therapy: a multicentre study.
    Garcia-Ruiz PJ; Martinez Castrillo JC; Alonso-Canovas A; Herranz Barcenas A; Vela L; Sanchez Alonso P; Mata M; Olmedilla Gonzalez N; Mahillo Fernandez I
    J Neurol Neurosurg Psychiatry; 2014 Aug; 85(8):840-4. PubMed ID: 24434037
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Impulse control and related disorders in Parkinson's disease.
    Weintraub D; Nirenberg MJ
    Neurodegener Dis; 2013; 11(2):63-71. PubMed ID: 23038208
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prevalence and pharmacological factors associated with impulse-control disorder symptoms in patients with Parkinson disease.
    Perez-Lloret S; Rey MV; Fabre N; Ory F; Spampinato U; Brefel-Courbon C; Montastruc JL; Rascol O
    Clin Neuropharmacol; 2012; 35(6):261-5. PubMed ID: 23123689
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Extrastriatal dopaminergic changes in Parkinson's disease patients with impulse control disorders.
    Lee JY; Seo SH; Kim YK; Yoo HB; Kim YE; Song IC; Lee JS; Jeon BS
    J Neurol Neurosurg Psychiatry; 2014 Jan; 85(1):23-30. PubMed ID: 24023269
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Longitudinal clinical, cognitive, and neuroanatomical changes over 5 years in GBA-positive Parkinson's disease patients.
    Leocadi M; Canu E; Donzuso G; Stojkovic T; Basaia S; Kresojević N; Stankovic I; Sarasso E; Piramide N; Tomic A; Markovic V; Petrovic I; Stefanova E; Kostic VS; Filippi M; Agosta F
    J Neurol; 2022 Mar; 269(3):1485-1500. PubMed ID: 34297177
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.